Top

Reactions Weekly

Published in:

01-03-2024 | Blinatumomab | Case report

Blinatumomab

Immune effector cell-associated neurotoxicity syndrome

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Zhou H, et al. A Real-World Evidence on Effectiveness and Safety of Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia. Blood 142 (Suppl. 1): 5906, Nov 2023. Available from: URL: https://dx.doi.org/10.1182/blood-2023-178460 [abstract]

Title: Blinatumomab
Immune effector cell-associated neurotoxicity syndrome
Publication date: 01-03-2024
Publisher: Springer International Publishing
Keywords: Blinatumomab
Acute Lymphoblastic Leukemia
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-53964-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Blinatumomab

Immune effector cell-associated neurotoxicity syndrome

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Palbociclib

Osimertinib

Prednisone/tacrolimus

Luspatercept

Avatrombopag

Brentuximab vedotin